Semax
Published work describes an ACTH(4-10) analogue — a modified fragment of the hormone ACTH — and reports effects on the expression of neurotrophic (nerve-supporting) factors.
Full reference page →
Research area
Brain & Focus Research
Covers peptides studied for activity in the central nervous system, including neurotrophic factor expression, anxiolytic mechanisms, and the regulation of sleep architecture.
- Compound classes
- 3Compound classes
- Randomised human trials
- 10Randomised human trials
- Field references
- 12Field references
- Last retrieved
- 2026-08-03Last retrieved
Read at your level
The standard reading.
Neuroactive research studies peptides that act within the central nervous system. The brain uses a large and still-expanding catalogue of neuropeptides alongside classical neurotransmitters — signals that fine-tune circuits rather than simply switching them on or off, often shaping mood, alertness, appetite, the perception of pain, and how memories are locked in.
The orexin system is a useful illustration of what this field can achieve: a neuropeptide pathway characterised in the laboratory, connected to a human disorder of sleep regulation, and translated into medicines that act on it. Reviews describe it as one of the more complete translational stories in neuropeptide science.
Significance
Why this area is studied
Neuropeptide signalling works by adjustment rather than command, which makes it interesting and difficult in equal measure. A signal that turns a circuit’s responsiveness up or down rather than firing it directly can produce effects that are real but subtle, dependent on context, and hard to measure — exactly the conditions under which weak studies produce confident-sounding results.
Mechanism
The science, in plain terms
Neuromodulation
Rather than carrying a signal across a synapse, many neuropeptides alter how readily a circuit responds to other inputs. The same peptide can therefore have different effects depending on the state of the network it acts on.
Neurotrophic signalling
Some peptides are studied for effects on the production of growth factors that help neurons survive and that support synaptic plasticity — the changes in the connections between neurons that the literature associates with learning.
Crossing the barrier
The blood–brain barrier keeps out most large or electrically charged molecules, which is a defining constraint of this field. Delivery through the nose appears often in published studies precisely because it partly gets around that barrier.
Practice
How the research is conducted
The study designs that generate evidence in this area. Each carries its own interpretive limits — which is why the evidence hierarchy is worth reading alongside them.
- 01
Behavioural tests in rodents assessing memory, anxiety-like behaviour, and stress response
- 02
Functional neuroimaging and connectivity analysis in human volunteers
- 03
Electrophysiology measuring how a peptide changes the excitability of specific circuits
- 04
Receptor localisation studies mapping where in the brain a signal can act at all
Open questions
What researchers are still testing
These are questions under investigation, not expected outcomes. Listing them is a description of where the field’s attention currently sits — not a suggestion that any of them will resolve favourably.
- 01
Whether the memory-related (nootropic) and anti-anxiety (anxiolytic) effects reported in one national literature reproduce under the trial standards used elsewhere
- 02
How much of a peptide given through the nose actually reaches brain tissue in humans, and how consistently
- 03
Whether peptides that adjust stress and pain circuits in animal behavioural models do the same in human experience, which those models capture only roughly
Constraints
Limitations worth holding onto
Much of the clinical literature for compounds in this area is published in Russian and has not been replicated in Western trials to regulatory standard. Absence of replication is not evidence of absence — but it is a genuine gap, and it should weigh on how confidently the findings are read.
Behavioural outcomes are among the hardest to measure reliably. Effects on mood, focus, and memory are easily swayed by expectation, which is precisely what blinding and randomisation exist to control for and what uncontrolled reports cannot.
Index
Compound classes in this area
Selank
The literature describes Selank as a synthetic version of tuftsin, a peptide the body makes naturally.
Full reference page →
Delta sleep-inducing peptide
Reviews describe a small peptide (a nonapeptide) first isolated from blood draining the brain, characterised in relation to sleep regulation.
Full reference page →
Sources
References for this field
Review articles covering the area as a whole, retrieved from PubMed. The explanatory sections above summarise what work of this kind reports.
This is a bibliographic and educational resource for research professionals. It is not medical, clinical, or legal advice, and nothing here is a recommendation to use any compound. Peptide research is an evolving field: what the literature contains changes as new work is published. Readers are responsible for evaluating the primary sources themselves and for consulting qualified professionals in their own jurisdiction.